Leaders from Across Children’s Hospital of Philadelphia Discuss COVID-19 Hot Topics

CHOP spokespeople continue to discuss the most pressing COVID-19 topics with news media across the country.
Read morePublished on in CHOP News
CHOP researchers have found that NTRK fusions are more common than expected in pediatric tumors, which could lead to better screening and treatment.
Published on in CHOP News, Cancer Connections
The FDA has approved a treatment that targets ALK mutations in relapsed, refractory ALK-positive anaplastic large cell lymphoma.
Published on in CHOP News
BE-WEHL is an in-home wellness program that includes mindfulness, deep breathing, yoga and infant or child massage education for the entire family.
Published on in CHOP News
A Phase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain.
Published on in CHOP News
In a proof-of-concept study, CHOP and Penn researchers have identified ionizable lipid nanoparticles that could be used to deliver mRNA as part of fetal therapy.
Published on in CHOP News
CHOP researchers identified an in vivo role for activated protein C (APC), which could potentially be exploited for future hemophilia A treatments.
Published on in CHOP News
Using a novel proteomics approach, CHOP researchers have identified a host protein that restricts herpes simplex virus 1 (HSV-1) infection.
Published on in CHOP News
In the largest clinical trial of its kind, researchers in a CHOP-led study found no benefit to higher red blood cell transfusions in preterm babies.
Published on in CHOP News
Findings suggest that risk of fractures occurring in later life could be identified in childhood and may lead to tailored interventions.
Published on in CHOP News
CHOP announced today it will name the emergency department in its new inpatient hospital in King of Prussia, PA after the late Madlyn K. Abramson, supported by a $2.5 million gift from The Abramson Family Foundation.